Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis
The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Type 3 immune response defined by increased IL-22 production drives fibrosis during chronic liver injury via enhanced TGF-β signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A exhibited similar pro-fibrotic activity in both animal studies and in human cells124,125”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [125]
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., & Cheroutre, H. (2007) · Science · doi:10.1126/science.1145697 · Cited by 1,982 · cited 3×
“3, eaar7754 (2018) 26 October 2018 12 of 15 TGF- is essential for the differentiation of both TH17 and Tregs (42) and given the reported plasticity between these two cell subsets (19), it is possible that liver inflammation mediated by TNF-, IL-1, and IL-6 indirectly promotes differentiation of Tregs into TH17 cells a…”
BackgroundInfluentialPathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809 · cited 3×
“Transforming growth factor– (TGF-) signaling is the key fibrogenic signal that activates hepatic stellate cells (HSCs), the main producer of extracellular matrix in the liver, and is modulated by proinflammatory mediators such as cytokines that act on HSCs and liver immune cells (1).”
BackgroundInfluentialThe aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B. (2008) · Nature · doi:10.1038/nature06881 · Cited by 1,634
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055 · cited 2×
“Type 2 inflammation, characterized by production of IL-4, IL-5, IL-10, IL-13, IL-25, and IL-33, is associated with reduced hepatic inflammation but correlates with progression of liver fibrosis (4).”
BackgroundTh17 and regulatory T cell balance in autoimmune and inflammatory diseases
Noack, M., & Miossec, P. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.12.004 · Cited by 932 · cited 4×
“The ratio between Tregs and other inflammatory cells is one of the key determinants of the progression of inflammatory diseases (18).”
BackgroundInfluentialMast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
Lin, A. M., Rubin, C. J., Khandpur, R., Wang, J. Y., Riblett, M., Yalavarthi, S., Villanueva, E. C., Shah, P., Kaplan, M. J., & Bruce, A. T. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100123 · Cited by 906 · cited 1×
“IL-17–producing mast cells are associated with disease progression in rheumatoid arthritis and psoriasis (40, 41), suggesting that they may have a similar function in the liver.”
BackgroundThe 3 major types of innate and adaptive cell-mediated effector immunity
Annunziato, F., Romagnani, C., & Romagnani, S. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.001 · Cited by 818 · cited 2×
“The inflammatory response can be divided into three types (2).”
BackgroundMeng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711 · cited 1×
“Although TH17 cells were not the principal source of IL-17 in situ, they may enhance recruitment of innate effectors through induction of proinflammatory chemokines by endothelial cells (7).”
Backgroundthe Immunological Genome Consortium, Robinette, M. L., Fuchs, A., Cortez, V. S., Lee, J. S., Wang, Y., Durum, S. K., Gilfillan, S., & Colonna, M. (2015) · Nature Immunology · doi:10.1038/ni.3094 · Cited by 641
Cited by
Items 101–163 of 163
Effects of injury size on local and systemic immune cell dynamics in volumetric muscle loss
Whitaker, R. C., Sung, S., Tylek, T., Risser, G. E., O’Brien, E. M., Chua, P. E., Li, T., Petrie, R. J., Han, L., Binder‐Markey, B. I., et al. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00397-z · Cited by 11
“If efferocytosis is impaired, neutrophils can progress to secondary necrosis and secrete soluble factors that promote a pro-in fl ammatory macrophage phenotype 22 – 24 .”
M. S. Barron, A., Fabre, T., & De, S. (2024) · F1000Research · doi:10.12688/f1000research.143472.1 · Cited by 8
“254,309 Elevated GM-CSF expression is also associated with NASH, IPF and mustard gaspulmonaryfibrosis.”
BackgroundInfluentialSelf-citationIL-22: A key inflammatory mediator as a biomarker and potential therapeutic target for lung cancer
Xu, L., Cao, P., Wang, J., Zhang, P., Hu, S., Cheng, C., & Wang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35901 · Cited by 9
“TGF-β is a pleiotropic regulatory cytokine that can regulate a variety of ILs including IL-22 and IL-17 to affect the composition of the tumor microenvironment [144].”
BackgroundIL-1b-Bearing NETs: Bridging Inflammation to Early Cirrhosis in Hepatitis B
Ntinopoulou, M., Konstantinidis, T. G., Chalkidou, A., Papagianni, E., Skeva, A., Panopoulou, M. I., & Chrysanthopoulou, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125733 · Cited by 9
“Markedly, IL-17-expressing neutrophils have been identified as activators of HSCs, enhancing fibrotic events [70].”
Processing of angiocrine alarmin IL-1α in endothelial cells promotes lung and liver fibrosis
Zhang, C., Ma, J., Zhang, X., Zhou, D., Cao, Z., Qiao, L., Chen, G., Yang, L. M., & Ding, B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112176 · Cited by 9
Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression
Laschtowitz, A., Lindberg, E. L., Liebhoff, A.-M., Liebig, L. A., Casar, C., Steinmann, S., Guillot, A., Xu, J., Schwinge, D., Trauner, M., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101267 · Cited by 15
Navigating the Paradox of IL‐22: Friend or Foe in Hepatic Health?
Qin, J., Zhu, W., & Zhou, W. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16991 · Cited by 8
“Consequently, HSC activation is stimulated, promoting liver fibrosis [118].”
The double-edged role of IL-22 in organ fibrosis
Chen, J., Lodi, R., Zhang, S., Su, Z., Wu, Y., & Xia, L. (2020) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2020.1799388 · Cited by 8
The Roles of T Cells in the Development of Metabolic Dysfunction‐Associated Steatohepatitis
Ge, Z., Wu, Q., Lv, C., & He, Q. (2025) · Immunology · doi:10.1111/imm.13943 · Cited by 8
“TGF-β induces HSCs to produce collagen and proinflammatory cytokines, promoting fibrosis and hepatic inflammation [12, 35, 46–48].”
Üremiş, N., & Üremiş, M. M. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70332 · Cited by 10
“Various mediators, such as tumor necrosis factor-alpha (TNF-α ), interleukin 17 (IL-17), interleukin 22 (IL-22), and transforming growth factor beta (TGF β ), regulate this response [76] (Figure 2).”
Li, S., Li, H., & Qi, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1533246 · Cited by 6
Sheriff, L., & Lalor, P. F. (2021) · Livers · doi:10.3390/livers1020007 · Cited by 7
HLA-G Is Widely Expressed by Mast Cells in Regions of Organ Fibrosis in the Liver, Lung and Kidney
Mouchet, N., Vu, N., Turlin, B., Rioux-Leclercq, N. C., Jouneau, S., Samson, M., & Amiot, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212490 · Cited by 7
Interleukin-22 acts as a mitochondrial protector
Hwang, S., Feng, D., & Gao, B. (2020) · Theranostics · doi:10.7150/thno.48022 · Cited by 7
“IL-22 is elevated in patients with chronic liver diseases such as viral hepatitis and advanced liver fibrosis [5, 19].”
BackgroundThe Roles of Neutrophil Cells in the Pathogenesis of Fibrosis: Mechanisms for Disease Progression
Zheng, Y., Xu, H., Guo, M., Yu, Y., & Wang, J. (2025) · The FASEB Journal · doi:10.1096/fj.202501715r · Cited by 7
“…human neutrophil peptides, both of which promote ROS Mouse/cell Increasing of fibrosis in mice with depletion of neutrophil NGAL [107] Mouse/cell Production of ECM and reduction of collagen synthesis in neutrophils IL-1β, TGF-β1 [108] production and stimulate HSC activation [87, 89, 90, 116–117].”
Nierath, W., Leitner, E., Reimann, S., Schwarz, R., Hinz, B., Bleich, A., Vollmar, B., & Zechner, D. (2024) · The FASEB Journal · doi:10.1096/fj.202400733r · Cited by 6
“75,76 These findings serve as robust evidence against the validity of the second hypothesis.”
Feješ, A., Belvončíková, P., Bečka, E., Strečanský, T., Pastorek, M., Janko, J., Filová, B., Babál, P., Šebeková, K., Borbélyová, V., et al. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i27.106166 · Cited by 8
Human Neutrophil α-Defensins 1–3 Are Upregulated in the Microenvironment of Fibrotic Liver
Fanne, R. A., Maraga, E., Kassem, E., Groisman, G. M., Amsalem, N., Zeina, A., Mouch, M. A., Taher, R., & Abu‐Mouch, S. (2023) · Medicina · doi:10.3390/medicina59030496 · Cited by 6
Gao, Y., Wu, Y., Guan, C., Cheng, N., Tong, Y., Wang, C., & Zhang, C. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01753 · Cited by 5
Hu, Z., Tian, D., Yang, Z., Zhang, J., Zhang, L., Xu, Y., & Lu, X. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1754721 · Cited by 7
“IL-17 and IL-22 released by T H 17 can stimulate the formation of transforming growth factor-β (TGF-β ), which promotes fibrosis by activating fibroblasts (Fabre et al., 2018).”
Talebi, M., Talebi, M., Farkhondeh, T., Simal‐Gándara, J., İlgün, S., Pourbagher‐Shahri, A. M., Samini, M., & Samarghandian, S. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998329724240918091335 · Cited by 12
Jiang, S., Jiang, Y., Feng, J., Hou, J., Qin, Z., Wang, Y., Yang, K., & Li, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114300 · Cited by 6
Sbierski‐Kind, J., Cautivo, K. M., Nilsson, J., Wagner, J., Dahlgren, M. W., Ewing-Crystal, N. A., Krasilnikov, M., Mroz, N. M., Ganslmeier, M., Lizama, C. O., et al. (2026) · Science Advances · doi:10.1126/sciadv.aea6805 · Cited by 3
“IL-17A has profibrogenic functions, promoting increased production of TGF-β ( 75 ), recruitment of pro-inflammatory neutrophils and monocytes, and activation of the STAT3 (signal transducer and activator of transcription 3) pathway that induces Col1 production in liver stromal cells ( 74 ).”
InfluentialUnraveling IL-17 and IL-22 role in occult hepatitis C versus chronic hepatitis C virus infection
Elbaz, S., Mousa, N., Elmetwalli, A., Abdel‐Razik, A., Salah, M., Elhammady, A. M., Abdelsalam, M., Abdelkader, E., El‐Wakeel, N., Eldars, W., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09032-6 · Cited by 3
“Previous studies have widely demonstrated the importance of IL-17 and IL-22 in regulating hepatic inflammation and fibrosis [21].”
Role of IL-17 cytokines in tubal fibrosis and infertility due to salpingitis
Zhao, J., & Liu, L. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11199-3 · Cited by 2
“IL-17 A, a pro-inflammatory cytokine, can induce fibrosis in multiple organ systems, including the lungs, liver, kidneys, heart, and skin [ 77–80 ].”
Nakata, R., Hosomi, S., Kobayashi, Y., Nishida, Y., Maruyama, H., Ominami, M., Nadatani, Y., Fukunaga, S., Otani, K., Kamata, N., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04386-w · Cited by 2
Wang, W.-T., Tian, J.-R., Gao, S., Wang, M.-B., Luo, Y., & Li, X. (2026) · Metabolites · doi:10.3390/metabo16020092 · Cited by 2
“In cirrhosis, neutrophil function is also disrupted by the dysfunctional gut–liver axis, leading to inflammation-associated hepatocyte injury and IL-17-dependent HSC activation [70].”
Wan, Y., Wang, T., Wang, K., Huo, Q., & Cheng, X. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116640 · Cited by 2
Sun, J., Yang, F., Li, Y., Li, S., & Song, J. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218527 · Cited by 3
Collaborative functionality between three types of inflammation in idiopathic pulmonary fibrosis
Fabre, T., Wynn, T. A., & Hart, K. M. (2026) · Nature Immunology · doi:10.1038/s41590-026-02616-1 · Cited by 2
“Indeed, unlike most antigen-driven immune responses, in which a predominant flavor of immune response dominates once clonal expansion of cytokine-producing CD4 + helper T cells (T H cells) occurs, many chronic fibrotic diseases are characterized by mixed inflammation 40,53,54 .”
InfluentialSelf-citationSinusoidal cell interactions—From soluble factors to exosomes
Ortega‐Ribera, M., Babuta, M., & Szabó, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00002-4 · Cited by 1
Neutrophil plasticity in liver diseases
Teo, J. M. N., Chen, W., & Ling, G. S. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae222 · Cited by 1
Ginsenoside Rg1 alleviated arsenic-induced liver fibrosis through modulating gut microbiome
Li, Y., Ren, Y., Jia, N., Zhang, X., Luo, Y., Cao, J., Yuan, Y., Wang, Z., Gong, Y., & Zhi, X. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107402 · Cited by 1
Abdelnabi, M. N., Maali, Y., Dabbaghizadeh, A., Mokariasl, N., Dion, J., Yamak, R., Soucy, G., Hassan, G. S., & Shoukry, N. H. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkaf332 · Cited by 1
Self-citationExperimental pulmonary arterial hypertension in mice with a pathogenic SOX17 variant
Shinya, Y., Hiraide, T., Momoi, M., Goto, S., Katsumata, Y., Inami, T., Hakamata, Y., Kataoka, M., & Ieda, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-46893-0 · Cited by 1
“The dose and administration schedule of CH223191 were determined based on previously published studies 18 .”
[Fibroblasts overpressing WNT2b cause impairment of intestinal mucosal barrier].
Xiao, S., Cheng, Y., Zhu, Y., Tang, R., Gu, J., Lan, L., He, Z., Liu, D., Geng, L., Cheng, Y., et al. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.02.07 · Cited by 1
Diagnosis of liver fibrosis using digital analysis
Kleczka, A., Mazur, B., Tomaszek, K., Dzik, R., & Kabała‐Dzik, A. (2023) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0053.9338 · Cited by 1
Defective epithelial barrier function in chronic inflammation of the intestinal mucosa
Delbue, D. (2021) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-31083 · Cited by 1
Lebeaupin, C., Donahue, K. L., Lal, S., Christensen, S. M., Asano, S., Wadsworth, M. H., Bound, K., De, S., McMahon, J., Schlerman, F., et al. (2025) · bioRxiv (preprint) · doi:10.64898/2025.12.17.694415
Self-citationModèle de fibrogenèse hépatique humaine : analyses immunopathologiques
Kartasheva-Ebertz, D. (2020) · theses.fr (ABES) · doi:10.70675/70f5a21azd6bbz487ez8d05zc9deb14b890b
JAMMIT Analysis Defines 2 Semi-Independent Immune Processes Common to 29 Solid TumorsPreprint
Zitello, E., Vo, M., Chen, S., Bowler, S. A., Khadka, V. S., Wenska, T., Hoffmann, P. R., Okimoto, G., & Deng, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.31.458339
Zhang, R., Chen, S., Chen, L., Ye, L., Jiang, Y., Peng, H., Guo, Z., Li, M., Jiang, X., Guo, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20154326
Zhang, R., Chen, S., Chen, L., Ye, L., Jiang, Y., Peng, H., Guo, Z., Li, M., Jiang, X., Guo, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20154320
Zhang, R., Chen, S., Chen, L., Ye, L., Jiang, Y., Peng, H., Guo, Z., Li, M., Jiang, X., Guo, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20154323
Zhang, R., Chen, S., Chen, L., Ye, L., Jiang, Y., Peng, H., Guo, Z., Li, M., Jiang, X., Guo, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20154329
Traitement contre les Leishmanies et réponse immune associé
Picard, M. (2022) · theses.fr (ABES) · doi:10.70675/c2e0f63ezaa2fz4822zb49aza0f00daa2711
Maali, Y., Fabre, T., & Shoukry, N. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00088-0
Self-citationLai, Y., & Dong, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00090-9
Zhao, S., & Gan, J. (2025) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2025.09.003
Martínez, E. M., Juárez‐Mercado, A. P., González‐Gallardo, A., Núñez-Ríos, J. D., Díaz‐Muñoz, M., Hernández-Muñoz, R. E., & Vázquez‐Cuevas, F. G. (2025) · Cells · doi:10.3390/cells14231845 · Cited by 1
Zhang, R., Chen, S., Chen, L., Ye, L., Jiang, Y., Peng, H., Guo, Z., Li, M., Jiang, X., Guo, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20154332
Zhang, R., Chen, S., Chen, L., Ye, L., Jiang, Y., Peng, H., Guo, Z., Li, M., Jiang, X., Guo, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20154317
WNT3a induces external anal sphincter fibrosis and dysfunction in rabbits
Thippeswamy, J., Mamachan, M., Shin, J., Rudramurthy, S. H., Selvam, M. K. P., Rajasekaran, M., & Mittal, R. K. (2026) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00349.2025 · Cited by 1
Thurairajah, B., Westfall, S., Chiggiato, L., Keogh, L., Sinha, A., Olsen, K. A., Gavino, C., Tafesse, Y., Moens, E., Lypaczewski, P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.28.721483
“However, protracted cytokine production by gd 17 T cells, particularly IL-17, has been implicated in diverse disease states including psoriasiform inflammation 16 , liver disease 17 , fibrosis 18,19 , autoimmunity 20 and colorectal cancer 21 .”
Liu, T., Gao, H., Wang, N., Wang, W., Cao, Z., Zhu, H., Liu, N., Gao, H., Ji, B., Liu, T., et al. (2026) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0014280
“Additionally, IL-17A has been reported to synergize with other cytokines such as TNF-α and IL-22 to promote fibrosis [27,28], suggesting that its depletion may disrupt a cooperative network essential for HSC activation.”
Lu, Z., Li, Y., Feng, J., Yang, S., Zhang, H., Chai, W., Yang, W., Wang, X., Gui, J., & Guo, Y. (2026) · Clinical Immunology · doi:10.1016/j.clim.2026.110713
Chang, F., Ge, S., Zhang, M. Y., Wu, F., Cao, F., Liu, J., Lei, M., Guo, Z., Tang, W., Chen, M., et al. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06257-3
“Th17 cells contributed to the progress of NAFLD by producing IL-17 and IL-22, leading to enhanced production of TGF-β in the liver, subsequently increasing collagen synthesis and triggering the release of pro-inflammatory cytokines by hepatic stellate cells [53 ].”
Unleashing innovative cross-organ fibrosis therapies by harnessing the omics revolution
Lebeaupin, C., Donahue, K. L., Dower, K., Wynn, T. A., Hart, K. M., & Fabre, T. (2026) · JCI Insight · doi:10.1172/jci.insight.200155
“In parallel, type 3 inflammation, characterized by IL-17 and IL-22/IL-23, enhances fibroblast TGF-β 1 receptor expression and neutrophil recruitment (55, 59, 60).”
Self-citationHBcAg-Induced IL-17F drives liver fibrosis in occult HBV infection
Liu, B., Huang, J., Hualong, Y., Liao, Q., Wang, M., Xu, R., Shan, Z., Zhong, H., Liao, F., Li, T., et al. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.04235-25
“The IL-17 cytokine family, particularly IL-17A and IL-17F, has been increasingly recognized as key regulators of inflammatory and fibrotic processes in various liver diseases (17, 22).”
Biomarkers From the Microbiome to Predict ALD Progression and Its Severity: A Comprehensive Review
Mishra, S., Solanki, H., & Mandal, P. (2026) · Mediators of Inflammation · doi:10.1155/mi/7244952
“Additionally, apart from an altered innate immune response, a distorted adaptive response is indicated by elevated levels of IL-17 and IL-22, driven by increased differentiation of Th17 cells and suppression of Tregs characterized by reduced FOXP3 expression [107, 108].”
Fernández, D., Geisse, A., González-Maldonado, P., Tapia, A., Gutiérrez-Ballesteros, F., Ugalde, V., Cáceres, F. T., Flores‐Santibáñez, F., Iwawaki, T., Pino‐Lagos, K., et al. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101877
“24 In *Authors share co-first authorship. this context, the identification of the APC subtype responsible for regulating intestinal type 3 immunity is a matter of intense research.”
Metadata
- Authors
- Fabre, T., Molina, M. F., Soucy, G., Goulet, J.-P., Willems, B., Villeneuve, J.-P., Bilodeau, M., & Shoukry, N. H.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Caprion (Canada) (CA)
- Corresponding author
- Shoukry, Naglaa H.
- ORCID
- Venue
- Science Immunology
- Published
- 2018-10-26
- Volume
- 3
- Issue
- 28
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W2898290288
- Cited by
- 155
- References
- 52
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 19 · 2023: 23 · 2022: 23 · 2021: 25 · 2020: 15 · 2019: 7 · 2018: 1
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (HEO-115696)
- Fonds de Recherche du Québec - Santé
- Canadian Liver Foundation (N/A)
- Fonds de recherche du Québec – Santé (FRQS) AIDS and Infectious Disease Network
- Canadian Network on Hepatitis C
- Novartis/Canadian Liver Foundation Hepatology Research Chair (N/A)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- liver fibrosis, IL-17A, IL-22, TGF-beta signaling, hepatic stellate cells, p38 MAPK, neutrophils, mast cells, IL-22RA1, aryl hydrocarbon receptor, chronic liver injury, thioacetamide, carbon tetrachloride
- MeSH terms
- Interleukin-22, Animals, Azo Compounds, Disease Models, Animal, Dose-Response Relationship, Drug, Female, Interleukins, Liver Cirrhosis, Male, Mice, Inbred C57BL, Pyrazoles, Transforming Growth Factor beta, Mice, Knockout, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.